Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Sanduzzi

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Scientific Reports|July 3, 2019
Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosisMarialuisa Bocchino, Dario Bruzzese, Michele D'Alto, et al.
The Journal of Rheumatology. Supplement|July 4, 2012
Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritisAlessandro Sanduzzi, Marialuisa Bocchino, Mariangela Atteno, et al.
BMC Pulmonary Medicine|April 1, 2020
Subclinical impairment of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea and preserved left ventricular ejection fractionAntonello D'Andrea, Angelo Canora, Simona Sperlongano, et al.
Clinical Immunology (Orlando, Fla.)|April 5, 2021
Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patientsFrancesco Perna, Sara Bruzzaniti, Erica Piemonte, et al.
Pulmonary Therapy|May 11, 2021
PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in ItalyCarlo Vancheri, Monica Bengus, Laura Bianchino, et al.
Pulmonary Pharmacology & Therapeutics|March 5, 2017
The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosisMarina Aiello, Giuseppina Bertorelli, Marialuisa Bocchino, et al.
Journal of Clinical Medicine|February 27, 2020
Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung DiseasesAgostino Buonauro, Ciro Santoro, Maurizio Galderisi, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 PneumoniaRiccardo Scotto, Biagio Pinchera, Francesco Perna, et al.
Oncotarget|May 4, 2018
Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancerMichela Terlizzi, Chiara Colarusso, Ilaria De Rosa, et al.
Clinical and Experimental Medicine|October 11, 2017
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI studyMichele D'Alto, Antonella Riccardi, Paola Argiento, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Scientific Reports|July 3, 2019
Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosisMarialuisa Bocchino, Dario Bruzzese, Michele D'Alto, et al.
The Journal of Rheumatology. Supplement|July 4, 2012
Screening and monitoring of latent tubercular infection in patients taking tumor necrosis factor-α blockers for psoriatic arthritisAlessandro Sanduzzi, Marialuisa Bocchino, Mariangela Atteno, et al.
BMC Pulmonary Medicine|April 1, 2020
Subclinical impairment of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea and preserved left ventricular ejection fractionAntonello D'Andrea, Angelo Canora, Simona Sperlongano, et al.
Clinical Immunology (Orlando, Fla.)|April 5, 2021
Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patientsFrancesco Perna, Sara Bruzzaniti, Erica Piemonte, et al.
Pulmonary Therapy|May 11, 2021
PerFECT 2.0: A Web-Based Platform Designed to Facilitate and Support the Diagnosis of Patients with Idiopathic Pulmonary Fibrosis in ItalyCarlo Vancheri, Monica Bengus, Laura Bianchino, et al.
Pulmonary Pharmacology & Therapeutics|March 5, 2017
The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosisMarina Aiello, Giuseppina Bertorelli, Marialuisa Bocchino, et al.
Journal of Clinical Medicine|February 27, 2020
Impaired Right and Left Ventricular Longitudinal Function in Patients with Fibrotic Interstitial Lung DiseasesAgostino Buonauro, Ciro Santoro, Maurizio Galderisi, et al.
International Journal of Environmental Research and Public Health|March 6, 2021
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 PneumoniaRiccardo Scotto, Biagio Pinchera, Francesco Perna, et al.
Oncotarget|May 4, 2018
Circulating and tumor-associated caspase-4: a novel diagnostic and prognostic biomarker for non-small cell lung cancerMichela Terlizzi, Chiara Colarusso, Ilaria De Rosa, et al.
Clinical and Experimental Medicine|October 11, 2017
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI studyMichele D'Alto, Antonella Riccardi, Paola Argiento, et al.
Pageof 11